Timothy E. Guertin Is Appointed to Varex Board of Directors: Provides Strong Corporate Governance Experience

September 3, 2020

Timothy E. Guertin has been appointed to the Varex Imaging Board of Directors. The news was announced today.

Timothy E. Guertin is a member of the Board of Directors at Teradyne Inc., a maker of automated test equipment and industrial robotics, and Chair of the Global Access to Cancer Care Foundation, which works to expand the availability of modern cancer care in developing countries. He is the former Chief Executive Officer of Varian Medical Systems, Inc., a cancer care technologies and solutions company, where during his more than 35-year tenure with the company he held a number of senior management positions, including Executive Vice President and Chief Operating Officer, as well as President of Varian’s Oncology business unit. In connection with this appointment, the Varex Board increased its size to eight directors.

“I am very pleased to have Tim join the Varex Board of Directors. He is a seasoned board member with strong corporate governance experience and a highly accomplished corporate executive with deep knowledge of X-ray imaging technologies. Tim’s experience in both the medical and industrial verticals and segments will be an asset to the company, and we welcome him to our Board of Directors,” said Ruediger Naumann-Etienne, Chairman of the Board of Directors of Varex Imaging Corporation.

Mr. Guertin served on the board of Varian Medical Systems from 2005 to 2020, and on the board of KCI Holdings, Inc., a wound care company, until it was purchased by 3M in 2019. He has served as Vice-Chair of the Silicon Valley Leadership Group and as Treasurer of the Board of Trustees of the Radiation Oncology Institute, a cancer research organization. He is a graduate of the University of California at Berkeley with a BS degree in Electrical Engineering and Computer Sciences.

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.